Established in August 21st, 2025, Gneo Biosciences is a rapidly growing pharmaceutical company engaged in the manufacturing and marketing of a wide range of high-quality healthcare products. Our diverse product portfolio includes Bilagen-M Tablets,
Gneocal-Plus K2-7 Tablets,
Gneocal-500 Tablets,
Rabgneo-D Capsules,
Neoflute-P Tablets,
Gneomol-250 Suspension, and
Gneovit Plus Capsules, and several other trusted formulations.
As a customer-centric organization, we place strong emphasis on understanding and fulfilling the specific needs of our clients. Our products are widely recognized and appreciated for their quality, efficacy, and reliability, and we ensure they are made available at competitive and affordable prices.
Our vision is to become the most preferred supply partner for our customers by achieving sustained growth through the consistent delivery of innovative, world-class, and customer-focused pharmaceutical products. We define our success not only by business performance but also by our positive impact on the communities we serve and by fostering a supportive, growth-oriented work environment for our employees.
We deliver superior products and continually enhance our technology to meet the highest standards
Trust and commitment are central to our model, driving every client relationship and ensuring.
We tackle challenges with customized reports that drive research excellence and deliver results.
To achieve total customer satisfaction, we'll do our greatest to know our customer’s requirements.
